Literature DB >> 3342290

Interferon-alpha induction of lymphocytes containing parallel tubular structures.

Y L Hoogeveen1, J W Smit, N R Blom, M J van Luyn, R M Halie.   

Abstract

The induction by IFN-alpha in peripheral blood lymphocytes of parallel tubular structures (PTS) and/or electron-dense granules occurring in a minority of peripheral blood lymphocytes was examined. IFN reportedly augments natural killer (NK) cell activity of large granular lymphocytes (LGL); these cells contain PTS and/or electron-dense granules. Normal peripheral blood mononuclear cells were incubated with IFN-alpha and surface antigen expression was measured by means of indirect immunofluorescence and, at the ultrastructural level, using gold labelled monoclonal antibodies. Surface antigen reactivity with the monoclonal antibodies OKT 3, 4, 8 and Anti-Leu-7 (HNK-1) showed no difference between the IFN-alpha incubation and non-IFN-alpha groups. However, electron microscope investigation revealed significant absolute increases in the percentage of OKT 8+ and Anti-Leu-7+ cells which were PTS-positive after IFN-alpha treatment compared with the control groups. The cytotoxicity assay using the K562 cell line showed enhanced lytic activity. Our results suggest that cells coexpressing the OKT 8 and Leu-7 antigens may be responsible for a minor proportion of the increase in PTS but that IFN-alpha mainly induces PTS and/or associated structures in cells which express the OKT 8+ antigen. These PTS+/OKT 8+ cells may contribute to enhanced cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342290     DOI: 10.1007/bf00633462

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  30 in total

1.  A large subpopulation of lymphocytes with T helper phenotype (Leu-3/T4+) exhibits the property of binding to NK cell targets and granular lymphocyte morphology.

Authors:  A Velardi; C E Grossi; M D Cooper
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

Review 2.  Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets.

Authors:  E Saksela; T Timonen; A Ranki; P Häyry
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Mode of action of interferon-mediated modulation of natural killer cytotoxic activity: recruitment of pre-NK cells and enhanced kinetics of lysis.

Authors:  A Silva; B Bonavida; S Targan
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

4.  Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.

Authors:  J M Zarling; L Eskra; E C Borden; J Horoszewicz; W A Carter
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

Review 5.  Human natural killer cells: biologic and pathologic aspects.

Authors:  G Trinchieri; B Perussia
Journal:  Lab Invest       Date:  1984-05       Impact factor: 5.662

6.  Enhancement of human natural killer cells by interferon requires RNA and protein synthesis.

Authors:  G A Bishop; S A Schwartz
Journal:  Clin Immunol Immunopathol       Date:  1982-12

7.  Lymphocytes with parallel tubular structures: morphologically a distinctive subpopulation.

Authors:  J W Smit; N R Blom; M van Luyn; M R Halie
Journal:  Blut       Date:  1983-06

8.  Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules.

Authors:  C E Grossi; A Cadoni; A Zicca; A Leprini; M Ferrarini
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

9.  The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity.

Authors:  R A Dempsey; C A Dinarello; J W Mier; L J Rosenwasser; M Allegretta; T E Brown; D R Parkinson
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

10.  Human large granular lymphocytes and natural killing ultrastructural studies of strontium-induced degranulation.

Authors:  P A Neighbour; H S Huberman; Y Kress
Journal:  Eur J Immunol       Date:  1982-07       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.